A gene therapy approach for treating T-cell-mediated autoimmune diseases.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMID 11159513)

Published in Blood on February 15, 2001

Authors

C Chen1, A Rivera, N Ron, J P Dougherty, Y Ron

Author Affiliations

1: Department of Molecular Genetics and Microbiology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ, USA.

Articles citing this

B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin Immunol (2011) 1.44

Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy. Mol Ther (2010) 0.98

Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag. Proc Natl Acad Sci U S A (2013) 0.96

MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA. Virology (2012) 0.93

Identification of a retroviral receptor used by an envelope protein derived by peptide library screening. Proc Natl Acad Sci U S A (2007) 0.91

B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance. Front Microbiol (2011) 0.90

Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection. J Virol (2002) 0.84

Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein. J Virol Methods (2013) 0.84

Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein. J Virol (2003) 0.84

Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis. Clin Dev Immunol (2013) 0.82

Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells. PLoS One (2012) 0.82

G100R mutation within 4070A murine leukemia virus Env increases virus receptor binding, kinetics of entry, and viral transduction efficiency. J Virol (2003) 0.81

Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen. Mol Ther (2009) 0.79

'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides. PLoS One (2011) 0.78

Phosphorylation Requirement of Murine Leukemia Virus p12. J Virol (2016) 0.77

Repression of the Chromatin-Tethering Domain of Murine Leukemia Virus p12. J Virol (2016) 0.76

(1) 0.75

Articles by these authors

High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57

High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol (2000) 3.09

The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones. Nucleic Acids Res (1988) 2.95

T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol (1987) 2.93

Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Hum Mol Genet (1998) 2.68

T cell selection in the thymus. Immunol Rev (1988) 2.53

The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res (2001) 2.51

Stimulation of in vitro transcription from heterologous promoters by the simian virus 40 enhancer. Proc Natl Acad Sci U S A (1984) 2.44

Definitions of infection for surveillance in long-term care facilities. Am J Infect Control (1991) 2.33

Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J Exp Med (1991) 2.25

A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13

Tomato SP-interacting proteins define a conserved signaling system that regulates shoot architecture and flowering. Plant Cell (2001) 2.11

Compartmentalization of MHC class II gene expression in transgenic mice. Cell (1988) 2.08

Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet (2000) 2.02

Accelerated sea-level rise from West Antarctica. Science (2004) 1.99

Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis (2003) 1.92

Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology (1996) 1.85

Mechanisms of retroviral mutation. Trends Microbiol (1996) 1.85

Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J Biol Chem (1992) 1.73

Analgesic effect of topical sodium diclofenac 0.1% drops during retinal laser photocoagulation. Br J Ophthalmol (2000) 1.64

Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol (2001) 1.63

Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62

Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J (1999) 1.61

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD. Aliment Pharmacol Ther (2012) 1.57

Immobilization of DNA via oligonucleotides containing an aldehyde or carboxylic acid group at the 5' terminus. Nucleic Acids Res (1987) 1.55

The nature of human immunodeficiency virus type 1 strand transfers. J Biol Chem (1998) 1.52

[Complications related with cocaine abuse that required hospital admission]. Rev Clin Esp (2008) 1.51

Inducible human immunodeficiency virus type 1 packaging cell lines. J Virol (1996) 1.49

Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur J Immunol (1981) 1.49

Molecular mass distribution of sodium alginate by high-performance size-exclusion chromatography. J Chromatogr A (1999) 1.44

Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol (1983) 1.42

Nesidiodysplasia--a histologic entity? Hum Pathol (1988) 1.42

Exclusive breast-feeding duration is associated with attitudinal, socioeconomic and biocultural determinants in three Latin American countries. J Nutr (1995) 1.40

Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein. J Biol Chem (1987) 1.40

Breastfeeding promotion and priority setting in health. Health Policy Plan (1996) 1.38

Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice. Cell (1989) 1.37

Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol (2001) 1.36

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol Immunother (2000) 1.35

Interferon, double-stranded RNA, and RNA degradation. Isolation of homogeneous pppA(2'p5'A)n-1 synthetase from Ehrlich ascites tumor cells. J Biol Chem (1980) 1.30

Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol (1998) 1.26

Dopamine D5 receptors of rat and human brain. Neuroscience (2000) 1.25

Fabry disease: a review of current management strategies. QJM (2010) 1.24

In vivo analysis of a new lacZ retrovirus vector suitable for cell lineage marking in avian and other species. Exp Cell Res (1991) 1.24

Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol (1995) 1.23

Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol (1999) 1.22

High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J Virol (1993) 1.21

Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension (1997) 1.21

Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl (2008) 1.21

Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans R Soc Trop Med Hyg (1998) 1.20

Mutations of conserved cysteine residues in the CWLC motif of the oncoretrovirus SU protein affect maturation and translocation. Virology (1995) 1.17

Restricted tissue distribution of Mlsa determinants. Stimulation of Mlsa-reactive T cells by B cells but not by dendritic cells or macrophages. J Exp Med (1989) 1.16

Juxtaposition of an active promoter to vsp genes via site-specific DNA inversions generates antigenic variation in Mycoplasma bovis. J Bacteriol (2001) 1.15

HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med (1987) 1.15

Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev (2008) 1.15

Rapid hybridization kinetics of DNA attached to submicron latex particles. Nucleic Acids Res (1987) 1.13

Intrachromosomal recombination within the vsp locus of Mycoplasma bovis generates a chimeric variable surface lipoprotein antigen. Infect Immun (2001) 1.11

Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables. Cancer (1990) 1.08

Spleen necrosis virus, an avian retrovirus, can infect primate cells. J Virol (1991) 1.05

A pilot study to collect micro-activity data of two- to four-year-old farm labor children in Salinas Valley, California. J Expo Anal Environ Epidemiol (1995) 1.05

Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol (1992) 1.04

Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther (2010) 1.04

Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index. Lupus (1999) 1.03

Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol (Oxf) (2006) 1.02

Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing. Nature (1980) 1.01

A nickel chelate microtiter plate assay for six histidine-containing proteins. Anal Biochem (1996) 1.00

Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst (1981) 0.99

Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group. J Virol (1992) 0.99

H-2 gene products influence susceptibility of target thyroid gland to damage in experimental autoimmune thyroiditis. Eur J Immunol (1980) 0.99

Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med (1996) 0.97

Physiologic levels of uric acid inhibit xanthine oxidase in human plasma. Pediatr Res (1993) 0.97

Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon. J Biol Chem (1980) 0.96

Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci (2001) 0.96

Prolonged survival in vivo of unprimed B cells responsive to a T-independent antigen. J Exp Med (1985) 0.96

Age, renal perfusion and function in island-dwelling indigenous Kuna Amerinds of Panama. Nephron (1999) 0.96

Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J Neural Transm (Vienna) (2006) 0.95

T cell specificity in twice-irradiated F1----parent bone marrow chimeras: failure to detect a role for immigrant marrow-derived cells in imprinting intrathymic H-2 restriction. J Immunol (1986) 0.95

Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol (2000) 0.95

Induction of MHC-restricted specificity and tolerance in the thymus. Immunol Res (1986) 0.95

An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology (2001) 0.95

Pulmonary pathology in Gaucher's disease. Hum Pathol (1999) 0.94

Demonstration of Borrelia burgdorferi sensu stricto infection in ticks from the northeast of Mexico. Clin Microbiol Infect (2009) 0.94

Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2. J Neural Transm (Vienna) (2004) 0.94

In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J Immunol (1993) 0.93

Merkel cell tumor masquerading as granulation tissue on a teenager's toe. Am J Dermatopathol (1992) 0.93

Experimental myocarditis: in vitro and in vivo studies of lymphocytes sensitized to heart extracts and group A streptococci. Immunology (1971) 0.93